Previous 10 | Next 10 |
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its second-quarter 2023 financial results before the market opens on Tuesday, August 1, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings releas...
IQVIA ™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life science industry, today announced that it has been recognized along with the National Basketball Association and partners at Harvard, Columbia and BioRefe...
2023-07-02 12:00:52 ET The tables have turned for Contract services organizations (CROs), with their toplines under pressure amid a post-pandemic drop in demand for clinical trial services worsened by biotech’s funding woes. The group offers clinical trial management services for...
IQVIA™ (NYSE:IQV), a global provider of data, analytics, technology solutions and services to the life sciences industry, was recognized as the highest scoring provider in the ‘Leader’ category of Everest Group’s Life Sciences Sales and Marketing Operations PEAK Assess...
IQVIA ™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life science industry, today announced that it has been selected as winner of the “Best AI-based Solution for Healthcare” award in the sixth annu...
IQVIA™ (NYSE:IQV) today announced the launch of IQVIA RIM Smart Labeling , a comprehensive labeling solution for the life sciences industry that provides an intelligence-driven approach for more efficient and compliant global label management. Through this unique solution, life science...
2023-06-02 01:29:17 ET Summary Duquesne Family Office's 13F portfolio value increased by 14% to $2.31B in Q1 2023, with 29 securities significantly large. Microsoft, Alphabet, Amazon, IQVIA Holdings, News Corp, and Taiwan Semi were among the new stakes established during the quart...
2023-05-25 05:47:53 ET IQVIA ( NYSE: IQV ) said it entered a $5M impact partnership with (RED), an organization co-founded by Bono and Bobby Shriver, to fight AIDS and to bolster laboratory system for pandemic preparedness. The partnership will provide money to the Laborato...
IQVIA ™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life science industry, announced a groundbreaking partnership today with (RED), the organization co-founded by Bono and Bobby Shriver to fight AIDS and the inj...
Spending on cancer medicines is expected to reach $375Bn globally by 2027, up from $196Bn in 2022 For approved medicines, the number of patients treated globally has increased annually by an average of 5% over the past five years Oncology trial starts remained at historically high...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...